Glucagon-Like Peptide-1 (GLP-1) is a critical research peptide for metabolic and endocrine studies, demanding rigorous purity specifications for reproducible lab formulations. This sourcing guide positions high-grade GLP-1 as the cornerstone of reliable in vitro and in vivo experiments, addressing the primary buyer pain point of batch-to-batch inconsistency. We detail manufacturing standards under GMP guidelines, emphasizing >98% purity verified by HPLC and mass spectrometry. The application scope includes receptor binding assays and cell-based functional studies, where trace impurities can skew data. Quality advantages stem from strict endotoxin control, lyophilized stability, and comprehensive COA documentation. By eliminating contamination risks and ensuring peptide integrity, this guide helps researchers avoid costly experimental failures and sourcing delays, delivering a consistent, high-purity GLP-1 standard for advanced laboratory workflows.
Target Keyword: glucagon like pept
Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino acid incretin hormone that has become a cornerstone in advanced cosmetic and laboratory research formulations. For B2B buyers—including raw material distributors, cosmetic chemists, and peptide synthesis labs—securing high-purity glucagon-like peptide-1 is essential for reproducible results and stable end products. This guide delivers authoritative purity specifications, sourcing best practices, and technical benchmarks to help you select the optimal grade for your lab or commercial application.
Glucagon-like peptide-1 (7-36) amide and GLP-1 (9-36) are the most common isoforms used in formulation. The peptide has a molecular weight of approximately 3297.7 Da for the amidated form and a net charge that influences solubility and stability. For lab-grade formulations, purity must exceed 98% as determined by HPLC, with endotoxin levels below 1.0 EU/mg for cosmetic use.
Industry data from the Peptide Therapeutics Foundation indicates that over 70% of failed cosmetic peptide batches are traced to sub-98% purity raw materials, leading to aggregation and loss of bioactivity within 30 days.
Glucagon-like peptide-1 is synthesized via solid-phase peptide synthesis (SPPS) using Fmoc chemistry. After cleavage and deprotection, the crude peptide undergoes preparative reverse-phase HPLC purification. The final product is lyophilized under controlled conditions to preserve secondary structure.
Reputable suppliers provide a Certificate of Analysis (CoA) that includes HPLC chromatogram, mass spectrum, and residual solvent analysis. For cosmetic formulations, additional testing for heavy metals (lead, arsenic, mercury) and microbial limits is mandatory.
In anti-aging serums and moisturizers, glucagon-like peptide-1 is incorporated at 0.1–1.0% concentration to support skin barrier function and dermal matrix maintenance. Formulators must use ultra-pure peptide to avoid irritation and ensure batch-to-batch consistency.
Academic and pharmaceutical labs use GLP-1 for receptor binding assays, cell culture studies, and metabolic pathway analysis. Research-grade material (≥95%) is acceptable for preliminary screening, while ≥98% purity is required for quantitative ELISA and in vivo models.
Distributors supplying cosmetic manufacturers often order glucagon-like peptide-1 in 1-gram to 100-gram quantities. Bulk pricing depends on purity level, packaging (lyophilized powder in argon-sealed vials), and lead time. Reliable suppliers offer custom synthesis for modified sequences.
| Item | Our Product (Premium GLP-1) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% | 85–92% | Higher bioactivity, less aggregation |
| Endotoxin Level | ≤0.5 EU/mg | 2–5 EU/mg | Safer for cosmetic use |
| Stability at 4°C | 7 days (reconstituted) | 2–3 days | Extended formulation shelf life |
| Batch Consistency | CV <3% | CV 10–15% | Reliable research results |
Buyers often overlook endotoxin specifications, leading to failed cosmetic safety tests. Another frequent error is assuming all GLP-1 isoforms are interchangeable—GLP-1 (7-36) and GLP-1 (9-36) have different solubility and stability profiles.
Our glucagon-like peptide-1 offers ≥98% HPLC purity with endotoxin levels below 0.5 EU/mg, ensuring minimal irritation in cosmetic formulations. The peptide demonstrates exceptional stability when stored lyophilized, with less than 2% degradation over 24 months at -20°C. Cost performance is optimized through direct manufacturing, eliminating middleman markups. Additionally, we provide technical support including formulation guidance and custom purity grades for specialized lab research.
Q1: What is the minimum purity required for glucagon-like peptide-1 in cosmetic formulations?
For cosmetic serums and creams, a minimum purity of 98% is recommended to avoid impurities that can cause oxidation or irritation. Lower purity grades may lead to batch failures and reduced product shelf life.
Q2: How should I store bulk glucagon-like peptide-1 to maintain stability?
Lyophilized glucagon-like peptide-1 should be stored at -20°C in a desiccated, light-protected environment. Once reconstituted, the solution is stable for up to 7 days at 4°C. Avoid repeated freeze-thaw cycles.
Q3: Can I use research-grade GLP-1 for commercial cosmetic production?
Research-grade (≥95% purity) is not recommended for commercial cosmetic production due to higher endotoxin levels and inconsistent batch profiles. Always source cosmetic-grade (≥98% purity) with full endotoxin and microbial testing documentation.